Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period, (in shares) at Dec. 31, 2019			115,120,000
Balance at beginning of period at Dec. 31, 2019	$ 1,143,683	$ (558)	$ 115	$ 1,127,487	$ (19,986)	$ 36,067	$ (558)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	306,276					306,276
Other comprehensive income (loss)	15,254				15,254
Dividends declared	(156,045)					(156,045)
Net issuances of restricted stock (in shares)			879,000
Net issuances of restricted stock	0		$ 1	(1)
Stock-based compensation expense	52,486			52,486
Repurchases of common stock, (in shares)			(2,871,000)
Repurchases of common stock	(155,807)		$ (3)			(155,804)
Balance at end of period, (in shares) at Dec. 31, 2020			113,128,000
Balance at end of period at Dec. 31, 2020	1,205,289		$ 113	1,179,972	(4,732)	29,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	598,626					598,626
Other comprehensive income (loss)	(17,890)				(17,890)
Dividends declared	(170,679)					(170,679)
Net issuances of restricted stock (in shares)			701,000
Net issuances of restricted stock	0		$ 1	(1)
Stock-based compensation expense	55,932			55,932
Repurchases of common stock, (in shares)			(3,143,000)
Repurchases of common stock	$ (290,227)		$ (3)			(290,224)
Balance at end of period, (in shares) at Dec. 31, 2021	110,685,989		110,686,000
Balance at end of period at Dec. 31, 2021	$ 1,381,051		$ 111	1,235,903	(22,622)	167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	657,919					657,919
Other comprehensive income (loss)	(21,001)				(21,001)
Dividends declared	(189,266)					(189,266)
Net issuances of restricted stock (in shares)			693,000
Net issuances of restricted stock	0		$ 1	(1)
Stock-based compensation expense	57,663			57,663
Repurchases of common stock, (in shares)			(3,681,000)
Repurchases of common stock	$ (317,808)		$ (4)			(317,804)
Balance at end of period, (in shares) at Dec. 31, 2022	107,698,498		107,698,000
Balance at end of period at Dec. 31, 2022	$ 1,568,558		$ 108	$ 1,293,565	$ (43,623)	$ 318,508